Artificial intelligence is becoming a core driver behind everything from semiconductors and cloud infrastructure to the large language models that power tools like ChatGPT, even as investors weigh higher energy costs, stubborn inflation risks and the prospect of tighter central bank policy. The AI Stocks screener helps you focus on companies that sit at the heart of this transition, whether they provide chips, software, data platforms or transformation services. This article highlights 3 stocks from that screener that stand out for their business exposure to the AI trend and may help you decide which AI opportunities are worth a closer look.
Overview: Aura Consolidated Group (ASX:AXQ) provides a broad digital safety platform for individuals, families and employees, covering identity theft protection, credit monitoring, online privacy tools, antivirus and device security, scam prevention and child online safety solutions in Australia and the United States.
Operations: Aura Consolidated Group generates around US$192.52 million in revenue, primarily from Security Software & Services in Australia.
Market Cap: A$1.06b
Aura Consolidated Group appears in the AI Stocks screener because it sits at the intersection of cyber safety, consumer subscription services and AI driven monitoring, with revenue of US$192.52 million. At the same time, the company is still reporting sizeable losses, has a Return on Equity that is deeply negative and less than one year of cash runway, which heightens funding risk, especially given its highly leveraged capital structure and illiquid shares. A fresh leadership bench, including a new Chief AI Officer and Chief Product Officer, highlights management’s focus on Aura Intelligence and product development. Evaluating how these changes may translate into a path toward more sustainable economics is a key consideration for investors conducting further research.
Aura Consolidated Group is pushing hard into AI driven cyber safety; however, heavy losses, high leverage and a short cash runway raise big questions about durability. Get the 1 key reward and 3 important warning signs (2 are major!)
Overview: Xero (ASX:XRO) runs a cloud based accounting platform that helps small businesses and their advisors handle bookkeeping, payroll, payments and tax in one place, supported by add ons like Planday for staff scheduling, Hubdoc for document capture and Syft for AI driven reporting and forecasting.
Operations: Xero generates about NZ$2.75b in revenue from providing online solutions for small businesses and their advisors, with customers across Australia, New Zealand, the United Kingdom, the United States and the Rest of World.
Market Cap: A$11.90b
Xero sits squarely in the AI Stocks screener because it is weaving AI directly into small business workflows, from Industry Benchmarks and analytics to the new JAX and XeroForce agent platforms that plug into tools like Microsoft 365 and Anthropic. Revenue of NZ$2,753.08 million on gross margins near 88% highlights a software model with meaningful operating leverage potential, even as net profit margins of 6.1% and a recent 26.5% earnings decline show that profitability is still a work in progress. Some analyst forecasts point to earnings growth above 30% a year and revenue growth above 16%, while the share price trading well below some cash flow based value estimates may appeal to investors who are comfortable with execution and funding risks.
Xero’s AI push, high gross margins and modest profits suggest the story is still being written. The real twist may lie in how those trends interact with valuation and execution risk in the analyst forecasts for Xero
Overview: Echo IQ (ASX:EIQ) uses artificial intelligence to help doctors spot structural heart disease earlier. Its EchoSolv software assesses risks such as aortic stenosis, diastolic dysfunction and heart failure, and the company is working with partners like Mayo Clinic to apply its cardiac risk tools to cancer patients.
Operations: Echo IQ currently generates about A$0.09m in revenue from developing artificial intelligence software.
Market Cap: A$991.29m
Echo IQ combines a small revenue base with a large A$991.29m market value and a focus on AI driven heart disease diagnostics that are already being deployed at major US institutions like Mount Sinai. This positioning is why it appears in the AI Stocks screener. Forecast revenue growth above 100% a year and links with Mayo Clinic indicate medical and commercial potential. However, investors also need to consider ongoing losses, reliance on external borrowing and a valuation that is high relative to some software peers. The mix of specialist healthcare relationships, recent changes in financial leadership and positive analyst views on the share price profile mean Echo IQ can be seen as a high risk, high potential AI healthcare stock that may merit closer research.
Echo IQ’s tiny A$0.09m revenue base compared with its A$991.29m valuation hints at a story investors may be missing, especially around growth expectations. Get the analyst forecasts for Echo IQ to see what could change this picture next
The three AI stocks in this article are only a starting point, as the full Artificial Intelligence/ AI Stocks screener surfaced 14 more companies directly plugged into chips, cloud, software and large language models that could also be worth a closer look. Use Simply Wall St to identify and analyze the specific catalysts, business models and AI narratives that matter most to you, so you can focus on the opportunities in this space that best align with your own views and research.
If Echo IQ or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Fresh stock ideas do not stay under the radar for long. Catch the next wave of breakout momentum while it matters, before prices start flying, and act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com